General Atlantic
Latest statistics and disclosures from General Atlantic's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALHC, XP, DLO, SQSP, ALKT, and represent 78.06% of General Atlantic's stock portfolio.
- Reduced shares in these 6 stocks: HRT (-$458M), ALKT (-$101M), HCM (-$67M), MBLY (-$38M), OPEN (-$19M), IMCR (-$7.6M).
- Sold out of its positions in HRT, HCM, MBLY, OPEN.
- General Atlantic was a net seller of stock by $-692M.
- General Atlantic has $3.5B in assets under management (AUM), dropping by -18.30%.
- Central Index Key (CIK): 0001017645
Tip: Access up to 7 years of quarterly data
Positions held by General Atlantic consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for General Atlantic
General Atlantic holds 18 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Alignment Healthcare (ALHC) | 20.5 | $721M | 61M | 11.82 |
|
|
| XP Cl A (XP) | 15.1 | $531M | 30M | 17.94 |
|
|
| Dlocal Cl A Com (DLO) | 14.5 | $511M | 64M | 8.00 |
|
|
| Squarespace Cl A (SQSP) | 14.0 | $493M | 11M | 46.43 |
|
|
| Alkami Technology (ALKT) | 13.9 | $490M | -17% | 16M | 31.54 |
|
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 4.4 | $155M | 9.7M | 15.99 |
|
|
| Akero Therapeutics (AKRO) | 4.3 | $150M | 5.2M | 28.69 |
|
|
| Pharvaris N V (PHVS) | 4.0 | $140M | 7.5M | 18.52 |
|
|
| European Wax Center Cl A Com (EWCZ) | 2.5 | $89M | 13M | 6.80 |
|
|
| Blend Labs Cl A (BLND) | 2.0 | $72M | 19M | 3.75 |
|
|
| Royalty Pharma Shs Cl A (RPRX) | 1.2 | $42M | 1.5M | 28.29 |
|
|
| Third Harmonic Bio (THRD) | 1.1 | $40M | 3.0M | 13.55 |
|
|
| Immunocore Ads (IMCR) | 1.1 | $39M | -16% | 1.3M | 31.13 |
|
| Riskified Shs Cl A (RSKD) | 0.7 | $25M | 5.3M | 4.73 |
|
|
| Acelyrin (SLRN) | 0.4 | $14M | 2.9M | 4.93 |
|
|
| Wish Cl A (LOGC) | 0.1 | $3.3M | 610k | 5.45 |
|
|
| Grove Collaborative Cl A Com (GROV) | 0.0 | $1.3M | 936k | 1.35 |
|
|
| Adagene Ads (ADAG) | 0.0 | $586k | 264k | 2.22 |
|
Past Filings by General Atlantic
SEC 13F filings are viewable for General Atlantic going back to 2010
- General Atlantic 2024 Q3 filed Nov. 12, 2024
- General Atlantic 2024 Q1 filed May 15, 2024
- General Atlantic 2023 Q3 filed Nov. 14, 2023
- General Atlantic 2023 Q2 filed Aug. 11, 2023
- General Atlantic 2023 Q1 filed May 15, 2023
- General Atlantic 2022 Q4 filed Feb. 14, 2023
- General Atlantic 2022 Q3 filed Nov. 14, 2022
- General Atlantic 2022 Q2 filed Aug. 12, 2022
- General Atlantic 2022 Q1 filed May 16, 2022
- General Atlantic 2021 Q4 filed Feb. 11, 2022
- General Atlantic 2021 Q3 filed Nov. 15, 2021
- General Atlantic 2021 Q2 filed Aug. 13, 2021
- General Atlantic 2021 Q1 filed May 17, 2021
- General Atlantic 2020 Q4 filed Feb. 12, 2021
- General Atlantic 2020 Q3 filed Nov. 13, 2020
- General Atlantic 2020 Q2 filed Aug. 13, 2020